Clark Golestani Biography and Net Worth

EVP of Merck & Co., Inc.

Clark Golestani has over 30 years of experience in health, life sciences and technology, and is an active investor, advisor and board member with a focus on the healthcare, life science and technology, media, and telecommunications (TMT) sectors. Mr. Golestani currently serves as the managing director of C Sensei Group, LLC an advisory services firm, as a senior advisor to New Mountain Capital based in New York City, NY, as an investment advisor to The CXO Fund based in Palo Alto, CA, a special advisor to the Dean at the University of Texas at Austin, Dell Medical School, and as a member of the DIA – Science and Policy Advisory Council.

What is Clark Golestani's net worth?: The estimated net worth of Clark Golestani is at least $1.50 million as of May 20th, 2016. Mr. Golestani owns 17,083 shares of Merck & Co., Inc. stock worth more than $1,504,295 as of March 26th. This net worth estimate does not reflect any other assets that Mr. Golestani may own. Learn More about Clark Golestani's net worth.
How do I contact Clark Golestani?: The corporate mailing address for Mr. Golestani and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at investor_relations@merck.com. Learn More on Clark Golestani's contact information.
Has Clark Golestani been buying or selling shares of Merck & Co., Inc.?: Clark Golestani has not been actively trading shares of Merck & Co., Inc. during the last ninety days. Most recently, Clark Golestani sold 3,000 shares of the business's stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $63.03, for a transaction totalling $189,090.00. Learn More on Clark Golestani's trading history.
Who are Merck & Co., Inc.'s active insiders?: Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), and Wendell Weeks (Director). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?: During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 1 times. They sold a total of 2,361 shares worth more than $209,562.36. The most recent insider tranaction occured on February, 6th when Director Inge G Thulin bought 2,833 shares worth more than $250,012.25. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..
Information on this page was last updated on 2/6/2025.

Clark Golestani Insider Trading History at Merck & Co., Inc.

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/10/2016	Sell	3,000	$63.03	$189,090.00
5/20/2016	Sell	39,877	$54.79	$2,184,860.83	17,083
2/14/2014	Sell	5,990	$55.47	$332,265.30	6,046

Clark Golestani Buying and Selling Activity at Merck & Co., Inc.

Merck & Co., Inc. Company Overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Today's Range

Now: $88.06

$87.31

$89.32

50 Day Range

MA: $92.35

$83.01

$100.72

2 Week Range

Now: $88.06

$81.04

$134.63

Volume

13,807,591 shs

Average Volume

10,310,121 shs

Market Capitalization

$222.44 billion

P/E Ratio

13.08

Dividend Yield

3.42%

Beta

0.35